FDA Publishes Draft Guidance On Psychedelic Drug Research

[Gunnar Larson]

FDA Publishes Draft Guidance On Psychedelic Drug Research

By Mike Curley

The U.S. Food and Drug Administration on Friday published a new draft
guidance highlighting considerations researchers should take into account
while investigating the use of psychedelic drugs like psilocybin for
treatment of medical conditions like depression and post-traumatic stress
disorder.

 1 document attached

https://www.law360.com/compliance/articles/1692241?nl_pk=e8718aa1-2adc-4c2d-8e21-50ac9491223a&utm_source=newsletter&utm_medium=email&utm_campaign=compliance&utm_content=2023-06-26&nlsidx=0&nlaidx=11
-------------- next part --------------
A non-text attachment was scrubbed...
Name: not available
Type: text/html
Size: 1064 bytes
Desc: not available
URL: <https://lists.cpunks.org/pipermail/cypherpunks/attachments/20230626/c262f350/attachment.txt>